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1. Introduction 
Articular cartilage covers the end of bones in joints and determines the load-bearing 
characteristics and mobility of joints. It has a thin, smooth, low friction surface with a 
remarkable resiliency to compressive forces.  In general, chondrocytes occupy lacunae in the 
matrix, and produce cartilaginous ECM (extracellular matrix), which consists of type II 
collagen (13%), proteoglycans (7%), and water (80%).  
Cartilage defects result from aging, joint injury, and developmental disorders, causing joint 
pain and loss of mobility. Articular cartilage is metabolically active, however, the 
chondrocytes have a slow turnover rate. Thus, articular cartilage might suffer progressive 
damage and degeneration with a limited spontaneous repair capability. Total joint 
arthroplasty is the final choice of treatment, however, it is not suitable for young patients 
because of the limited life span of the artificial joint. Marrow-stimulating techniques such as 
microfracturing, multiple drilling, mosaicplasty and autologous chondrocyte implantation 
are clinically available for young patients, but have some limitations (Ikada, 2006). Marrow-
stimulating techniques result in a fibrocartilage with less mechanical strength than hyaline 
cartilage and only limited repair capacity. The major problems with mosaicplasty are a 
limited availability of autologous tissue and donor site morbidity, the destruction of healthy 
non-weight-bearing tissue to repair diseased tissue. Autologous chondrocyte 
transplantation with a periosteal graft has shown encouraging results, however, 
predictability and reliability are still questionable.  
Ochi et al. (2002) showed a clinical advantage of transplanting autologous chondrocytes 
cultured in collagen gel for the treatment of full-thickness defects of cartilage in 28 knees 
over a minimum period of 25 months. Arthroscopic assessment indicated that 26 knees 
(93%) had a good or excellent outcome. Wakitani et al. (2002) applied cell transplantation to 
repair human articular cartilage defects in osteoarthritis knee joints. The study group 
comprised 24 patients with knee OA. Adherent cells expanded from bone marrow aspirates 
were embedded in collagen gel and transplanted into the articular cartilage defects of 12 
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knees, with the other 12 knees serving as cell-free controls. Arthroscopic and histological 
grading scores were better in the cell-transplanted group than cell-free group. 
In spite of these successful clinical results to expand the clinical treatment of cartilage 
diseases, we need to establish a three dimensional culture technique for regenerating large 
cartilage tissue in vitro.  One solution is to use an RWV (rotating wall vessel ) bioreactor. 
2. Regeneration of cartilaginous tissue from rabbit bone marrow cells under 
three dimensional culture by RWV bioreactor 
2.1 RWV (rotating wall vessel) bioreactor 
Recently, three-dimensional cell culture techniques have attracted much attention among 
not only cell and developmental biologists but also clinicians who have an interest in tissue 
engineering (Abbott, 2003). The limitations of two-dimensional culture using conventional 
flasks or dishes are becoming clear. In the field of tissue engineering, the chondrocyte cell is 
a typical example of the major difference between a flat layer of cells and a complex, three-
dimensional tissue (Holtzer, 1960; Passaretti et al., 2001). Matured chondrocytes in the two-
dimensional condition dedifferentiated without maintaining their phenotype and lost their 
original phenotype after four rounds of subculture. Clinically, a method of regenerating 
cartilage tissue needs to be established to treat diseases such as osteoarthritis. Thus, the 
development of a cell culture system for the growth of three-dimensional cartilage is 
important. However, problems such as necrosis due to high-density cell culture and shear 
stress have not yet been solved using conventional stirred fermentors. We examined the use 
of a rotating wall vessel (RWV) bioreactor that simulates a microgravity environment with 
low shear stress for cartilage tissue regeneration (Fig.1). This bioreactor generates stress by 
the horizontal rotation of a cylindrical vessel equipped with a gas exchange membrane. The 
RWV bioreactor compensates for the effect of gravity, resulting in homogenous cell growth 
and differentiation without sinking, and cells aggregate and form a three-dimensional 
tissue. The advantage of using an RWV bioreactor for tissue formation was first reviewed by 
Unsworth and Lelkes (1998), who discussed the benefits of growing tissues in microgravity 
and simulated microgravity. The formation of tissue by, for example, endothelial cells 
(Sanfold et al., 2002), colon carcinoma cell lines (Goodwin et al., 1992), ovarian cancer cells 
(Goodwin et al., 1997), osteoblasts (Qiu et al., 1999), and erythroid cells (Sytkowski and 
Davis, 2001), has been reported. In particular, the RWV bioreactor has been shown to 
stimulate chondrogenesis (Baker and Goodwin, 1997; Duke et al., 1993). Moreover, a 
comparison of chondrocyte cells cultured in rotating bioreactors in space (Mir space station) 
and on earth was reported by Freed et al. (1997a). They performed rotating cultures of 
bovine chondrocytes in polyglycolic acid (PGA) scaffolds and concluded that the culture on 
earth produced cartilage tissues closer to the natural form than that in space. In this case, the 
culture period for obtaining tissue was 7 months. Very recently, the chondrogenesis of 
human cartilage by an RWV bioreactor has been reported (Marlovits et al., 2003). Good 
quality cartilage tissue was formed by rotating culture from aged human articular cartilage 
after 90 days of cultivation. In spite of numerous studies on the formation of cartilage tissue 
from chondrocytes, our report (Ohyabu et al., 2006) was the first on the production of 
cartilaginous tissue from bone marrow-derived cells by rotating culture. A three- 
dimensional cell culture technique was established for the construction of large and 
homogenous cartilage tissues without a scaffold using bone marrow-derived cells and an 
RWV bioreactor. 
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Fig. 1. RWV Bioreactor 
 
 
Fig. 2. Time-dependence of the rotation speed 
2.2 Regeneration of cartilage tissue in vitro using rabbit bone marrow cells and an 
RWV bioreactor 
Bone marrow cells were collected from the femora of six 10-day-old Japanese white rabbits 
and cultured in a standard medium consisting of Dulbecco’s Modified Eagle’s 
Medium(DMEM) containing 10% fetal bovine serum for 3 weeks. The cells were 
resuspended in a chondrogenic differentiation medium comprising DMEM containing 10% 
FBS and 10 ng/mL of TGF-β (Johnstone et al., 1998) and seeded in the discoidal vessels of an 
RWV reactor in a CO2 incubator. A rotatory culture was performed for 4 weeks. The rotation 
speed was adjusted manually in order to keep cell aggregates  freely suspended within the 
vessel. As a control, a tube culture was performed, a kind of three dimensional culture 
technique developed by Holtzer and Manning (Holtzer, 1960; Manning and Bonner, 1967) 
and established by Johnstone et al. (1998).  After the rotating culture in the RWV vessel and 
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static culture in the conical tube, the aggregates were harvested and prepared for 
histochemical and biochemical analysis. 
 
 
Fig. 3. In vitro cartilage tissue regeneration from rabbit bone marrow cells using RWV 
bioreactor 
The rotation speed of the RWV was adjusted manually to prevent the cell aggregates from 
sinking in the RWV vessel. The speed was varied between 11 and 25 rpm and increased 
steadily for 28 days (Fig.2). The change in speed originated from the steady increase in the 
mass of tissue formed in the vessel. Figure 3 shows images of the tissue formed in the RWV 
vessel and in the 15-mL conical tube  after 1 and 4 weeks of culture. The tissues are of a 
cylindrical shape. The size (height/diameter) of the tissue in the RWV vessel was 1.00/0.48 
cm at 1 week; 1.28/0.53 cm at 2 weeks; and 1.25/0.60cm at 4 weeks. This kind of single 
tissue formed in the reactor reproducibly in the same experimental conditions. By contrast, 
the tissue formed in the 15-mL conical tube was smaller: 0.20/0.90 cm at 1 week; 0.20/0.55 
cm at 2 weeks; and 0.28/0.74 cm at 4 weeks. The qualities of the tissues as cartilage were 
evaluated by histochemical methods including immunostaining of collagen type I and 
collagen type II and safranin-O and toluidine blue staining(Fig.4). The staining of collagen 
type II was more intense in the RWV than tube culture The results of safranin-O and 
toluidine blue staining are clearer as shown in Figure 4c and d. The time course of safranin-
O and toluidine blue staining in the tissues formed in the tubes shows that the tissue 
gradually became chondrogenic. However, this change occurred faster in the RWV tissues. 
Even at 1 week, chondrogenesis occurred in the RWV tissues, but no sign of chondrogenesis 
was detected in the tissues in the tubes. At 2 weeks, the difference between the two was 
clearer, and at 4 weeks, chondrogenesis of the RWV tissues was confirmed by the strong and 
homogeneous matachromasy of safranin-O staining. Comparing the results of safranin-O 
staining, the RWV tissue at 1 week appeared to be in a similar stage of differentiation as the 
tube tissue at 4 weeks. In conclusion, we succeeded in the rapid regeneration of three-
dimensional large and homogeneous cartilaginous tissue from rabbit bone marrow cells 
without a scaffold using a RWV bioreactor. Bone marrow cells cultured for 3 weeks were 
resuspended and cultured for 4 weeks in the chondrogenic medium within the vessel. Large 
cylindrical cartilaginous tissue 1.25 cm in height and 0.60cm in diameter formed. Their 
cartilaginous properties were demonstrated by immunohistochemistry of collagen types I 
and II, mRNA expression of aggrecan, collagen types I and II, GAG/DNA ratio, toluidine 
blue, and safranin-O staining, and polarization. 
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Fig. 4. Immunostaining of collagen type I (a) and collagen type II (b), safranin-O staining (c), 
and toluidine blue staining (d) of the tissues formed in the RWV vessels and in the conical 
tubes at 1, 2 and 4 weeks. Bar.1 mm. (Ohyabu et al., 2006) 
Despite numerous studies on the formation of cartilage tissue from chondrocytes (Baker and 
Goodwin, 1997; Duke et al., 1993; Freed and Vunjak-Novakovic, 1997b; Freed et al., 1997a; 
Marlovits et al., 2003), no report has been published on the production of cartilage tissue 
from bone marrow-derived cells in rotating cultures. Stem cell-derived tissue formation is a 
basic concept in tissue engineering. However, three-dimensional cartilage tissue has not yet 
to be produced in rotating cultures. Our study showed that (1) in vitro chondrogenesis was 
observed in 3D culture of bone marrow stromal cells and that (2) RWV culture yielded 
cartilaginous tissues that was superior to static culture. As shown in Figure 4, the 
cartilaginous tissue is homogeneous and showed no necrotic cells of large size 1.25/0.6 cm.  
These results are encouraging and promising for cartilage tissue engineering, and an 
experiment in which the tissue formed by an RWV bioreactor as transplanted to large 
osteochondral defects described in the next paragraph. It is true that it is the first study to 
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utilize bone marrow stromal cells, but we can gain a lot of benefit by using bone marrow 
cells. First, the number of autologous cultured chondrocytes is limited and applicable to 
only a limited area of cartilage damage, while a greater number of chondrocytes can be 
cultured from bone marrow cells (Wakitani et al., 2004). From this point of view, the clinical 
applications of RWV using bone marrow cells are wider than those using autologous 
chondrocytes. Second, bone marrow cells might be suitable for cartilaginous tissue 
formation by RWV culture. It has been reported that the exposure to RWV at an early stage 
of chondrogenesis severely limits the ability for cartilage growth, however, at a late stage of 
chondrogenesis, the RWV environment is beneficial and enhances growth and development 
using embryonic mouse pre-bone tissues (Klement et al., 2004). These results seem to 
contradict our results obtained using bone marrow stromal cells. Bone marrow stromal cells 
might be more suitable for RWV culture than embryonic cells. There are two major 
differences between the RWV culture and tube culture. One is the way in which the cells 
aggregate gathered manually in the RWV, whereas  they gathered  due to centrifugal force 
in the tube. The other point is that the unique mechanical stress due to the medium flow and 
gravity continued to apply to the tissue in the RWV (Klaus, 2001; Klement et al., 2004). We 
speculate that the major reason that superior tissue formed in the RWV was that the 
appropriate mechanical force was applied to the naturally gathered cells. To study the 
methodology of cartilage regeneration from bone marrow cells, a comparison of the tissue 
engineered in the RWV bioreactor with and without a scaffold would be useful. This kind of 
study was published by our group (Ohyabu et al. 2009). 
2.3 Regeneration of cartilage tissue in vivo using rabbit bone marrow cells and an 
RWV bioreactor 
As described in the last section, the application of a rotating wall vessel (RWV) bioreactor 
that simulates a micro-gravity environment with low shear stress for regenerating cartilage 
tissue and successfully established a three-dimensional (3-D) cell culture technique for the 
formation of large and homogenous cartilaginous aggregates from bone marrow-derived 
cells without using a scaffold. This bioreactor generates stress through the horizontal 
rotation of a cylindrical vessel equipped with a gas exchange membrane. The bioreactor 
compensates for the effect of gravity, resulting in homogenous growth and differentiation 
without sinking, and the cells aggregate and form 3-D tissue.  This section describes the 
usefulness of transplanting cartilaginous aggregates formed from rabbit bone marrow-
derived cells using an RWV bioreactor (Yoshioka et al., 2007). 
Cylindrical defects 5x5 mm in area and 4 mm in depth were created on the patellar groove 
of the rabbit femur with a hand drill.  For the control, the defects were left empty (Group-C: 
control group, n=18), whereas 3-D cartilage aggregates of 10 mm x 5 mm (height x diameter) 
were placed into the defects without any flap (Group-T: transplanted group, n=18) as shown 
in Fig.5. The rabbits were then caged and allowed to move freely without any splinting 
before being sacrificed 4 (n=6), 8 (n=6) and 12 (n=6) weeks after the operation. Fig.5 shows a 
macroscopic view of defects of the patella groove of the knee and histological view of a 
section of osteochondral tissue 4 weeks after transplantation. Large osteochondral defects in 
the knee joints were successfully repaired with hyaline-like cartilage after the 
transplantation of allogeneic cartilaginous aggregates formed from bone marrow-derived 
cells using the RWV bioreactor. As early as 4 weeks after the operation, the defects were 
filled with reparative tissue that resembled hyaline cartilage. The reparative tissue had a 
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smooth surface and there were no fibrous tissues between the reparative tissue and adjacent 
normal cartilage. At 8 weeks, enchondral bone had formed in the deeper portion of the 
reparative tissue. At 12 weeks, in some cases the intensity of staining with safranin-O was 
slightly reduced in comparison to that in the adjacent normal cartilage, but the reparative 
tissue retained its thickness. This is the first report of the rapid regeneration of critical 
osteochondral defects with allogeneic cartilaginous aggregates formed from bone marrow-
derived cells without any scaffold using the RWV bioreactor. 
 
 
Fig. 5. Transplantation of RWV tissue into osteochondral defects in rabbit knees 
There are two important advantages. First, the cells are derived from bone marrow and 
mesenchymal stem cells (MSCs). Therefore it is possible for the cells to proliferate in a 
monolayer culture and then to differentiate into cartilage and bone (Pittenger et al.1999, 
Caplan 1991) . An additional advantage to using bone marrow-derived cells in a clinical 
context is that they can be collected through aspiration of both sides of the iliac crest under 
partial anesthesia, a procedure that is very easy to perform and minimally invasive.  Second, 
we used the RWV bioreactor as the 3-D culture system which stimulates chondrogenesis in a 
simulated micro-gravity environment (Unsworth et al. 1998). In previous reports (Wakitani 
et al. 1994, Im et al. 2001), engineered cartilage from MSCs required a scaffold for the cells to 
remain in the defect and to act as a support for inducing the formation of hyaline cartilage. 
However, using our technique, it is possible to form large and homogenous cartilaginous 
aggregates without any scaffold which can thus be transplanted into large osteochondral 
defects, which do not spontaneously regenerate in the rabbit (Shapiro et al. 1993). These 
aggregates have already produced an abundance of extracellular matrix and type-II collagen 
which was used to identify the chondrogenic phenotype in vitro. This suggests that the 
aggregates formed in the RWV bioreactor have the characteristics of hyaline cartilage. Rich 
extracellular matrix embedded chondrocytes to maintain their phenotype protecting them 
from dedifferentiation. In addition, we had a specific reason to choose aggregates at as early 
as 1 week after culture in the RWV bioreactor for transplantation. According to our in vitro 
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study(Ohyabu et al.2006), the cells of cartilaginous aggregates after 1 week of culture are not 
mature, but consist of undifferentiated or chondrogenic precursor cells, which might exhibit 
plasticity to differentiate into another phenotype such as osteoblasts etc. The aggregates of 
such cells were influenced by various biological factors from the host bone marrow side 
(Engstrand  2003, Wozney et al. 1990) and interacted with adjacent cartilage (Tognana et al. 
2005, Zhang et al. 2005). A suitable distribution of mechanical stress and synovial factors 
(Serink et al., 1997, Yanai et al. 2005) also influence the lineage of these cells. These 
characteristics may thus make it possible to rapidly and suitably regenerate cartilage-bone 
structure in vivo.  
3. Rotating three-dimensional dynamic culture of adult human bone marrow-
derived cells for tissue engineering of hyaline cartilage 
The method of constructing cartilage tissue from bone marrow-derived cells in vitro is 
considered a valuable technique for hyaline cartilage regenerative medicine. Using a 
rotating wall vessel (RWV) bioreactor originally developed to simulate a microgravity 
environment, we attempted to efficiently construct hyaline cartilage tissue from human 
bone marrow-derived cells without using a scaffold (Sakai et al., 2009).  
Bone marrow aspirates were taken from the iliac crests of 9 patients using an 11G Bone 
Marrow Harvest Needle during orthopaedic surgery (mean age of 36 years, range of 23-62 
years; Table1) as shown in Fig.6. Briefly, 10 ml of bone marrow sample with anticoagulant 
was mixed with 25 ml of phosphate-buffered saline, and 35 ml aliquots of bone marrow 
suspension were overlaid onto a poly-sucrose gradient and centrifuged at 1500 g for 15 min 
at room temperature. The cell layer was carefully removed and suspended and cultured in a 
growth medium. The growth medium consisted of Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics. Approximately 
2-3 weeks later, confluent cells were subcultured  and seeded on two representative culture 
systems (RWV culture and pellet culture) for chondrogenic differentiation using 
chondrogenic differentiation medium(described in section 2.2)..  
 
 
Table 1. Summary of data from 9 samples (Sakai et al. 2009) 
In spite of some studies on the formation of cartilage tissue from chondrocytes cells (Freed 
et al. 1997a; Marlovits et al. 2003), no report has been published on the production of 
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cartilage tissue from adult human bone marrow-derived cells including mesenchymal stem 
cells by rotating three-dimensional dynamic culture. After 2 weeks of differentiation and 
induction of adult human bone marrow-derived cells to form cartilage, the two culture 
methods were compared using the RWV bioreactor and the pellet culture as shown in Figs 7 
and 8. The RWV system produced a larger tissue rich in GAG and collagen II, which are 
specific components of the cellular matrix of hyaline cartilage. These results suggest that the 
culture under hydrodynamic conditions using the RWV bioreactor provides a more suitable 
environment for the induction of cartilage differentiation from adult human bone marrow-
derived cells than a conventional static culture system (pellet culture). 
 
 
Fig. 6. Brief schematic of experimental protocol (Sakai et al., 2009)  
In RWV cultures, rotating the culture medium in the vessel provides an ideal three-
dimensional system to achieve high-density cell agglutination and obtain a spatially 
extended extracellular matrix. Decreased shear stress due to the rotating culture fluid makes 
high-density cell agglutination possible and affords effective nutrition supply and excretion 
owing to the circulating fluid. As a result, this system provides high tissue production and 
high maintenance. Cells tend to retain their differentiated phenotype in vitro only if 
cultured under conditions that resemble their natural  environment in vivo. Therefore, it is 
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reasonable to think that the tissue engineering of cartilage must be conducted in a 
physiological and mechanical environment similar to that during the in vivo ontogeny of the 
embryo. The formation of cartilage starts with cell agglutination, after early agglutination, 
an important event for maturation and skeletal patterning (Hall et al., 1992).  The formation 
of bone and cartilage in the fetus occurs in a mechanical environment very similar to an 
environment with microgravity because the amniotic fluid provides buoyancy to the cells. 
Many studies have shown the effects of gravity and mechanical load on tissue, and a 
microgravity environment has considerable effect on tissue formation (Klement et al., 1994, 
2004; Freed et al., 1999). Furthermore, some studies have shown an effect of gravity on 
embryonic bone and cartilage formation. It has been confirmed that the gravity load on 
mesenchymal stem cells during the early embryonic stages is an important factor 
determining the orientation of differentiation, and that the effect of a microgravity 
environment on cells differs between stages; however, the effects of microgravity on the 
differentiation of mesenchymal stem cells into bone, cartilage and adipose tissue remain to 
be determined. From the results of this study, the pseudo-microgravity environment 
provided by the RWV bioreactor may facilitate the differentiation of mesenchymal stem 
cells into cartilage.  
 
 
Fig. 7. (A) Comparison of the tissue formed in the pellet culture and RWVculture. 
Macroscopic photograph after 14 days of pellet culture (left), using an RWV bioreactor 
(right). (b) Wet weight of the tissue construct after 14 days. Data are expressed as the mean 
SD (n=9). : p<0.05 (Sakai et al., 2009)  
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Fig. 8. Safranin-O/fast green staining of cell aggregates cultured using an RWV bioreactor(A, 
B) and pellet culture system (C). (Original magnification x40). Cell aggregates from 3 donors 
showed distinct staining with safranin-O (A). Cell aggregates from 6 donors cultured using an 
RWV bioreactor showed partial staining with safranin-O (B). Construct cultured using the 
pellet culture system showed faint and heterogeneous staining (C). (Sakai et al. 2009)  
4. Automatic rotation control system for RWV bioreactors 
The RWV bioreactor proved quite useful for the three-dimensional culture of mesenchymal 
cells as described above. This system is expected to be of laboratory use as well as clinical 
use, however, it currently requires manual control of the rotation speed to match the 
increase of mass of the growing tissue as shown in Fig. 2. To overcome this inconvenience, 
we developed an automatic rotation control system for the RWV bioreactor as shown in 
Fig.9. A method of catching the position of the cell aggregates in the rotating vessel is key. 
 
 
Fig. 9. Automatic Rotation Control System for RWV Bioreactors (for laboratory use) 
An image of the vessel containing a medium and a cell aggregate is shown in Fig.8. As 
commercially available culture mediums are colored pink or red, it is difficult to visualize 
aggregates in a rotating vessel equipped with valves etc. The complex structure of the vessel 
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prevent simple visualization of the cell aggregate with a CCD camera. Consequently, a 
tricky method was developed using a dual illumination system as shown in Fig.10. The tissue 
growing in the RWV vessel was observed using the CCD camera in front of the vessel, and 
visualized by two illumination systems, cold blue light and white light at the back and front of 
the vessel respectively, which enabled the visualization of only the tissue. By regulating the 
RGB signals from the CCD camera, it would be possible to get a masked image of the growing 
tissue. The control system calculates the position of the tissue and sends a feedback signal to 
adjust the rotation speed. This automatic system frees up technicians and students. 
 
 
Fig. 10. Principle of visualization of a tissue in RWV vessel: The visualized tissue is judged 
by the program as to whether it is in the preset rectangular area in the vessel or not, and the 
control system sends a feedback signal to the rotation system in the RWV bioreactor to 
increase or decrease the rotation speed if it is outside of this area 
5. GMP grade automatic RWV cell culture system 
For using an RWV bioreactor, for instance for cartilage regeneration therapy, a rough 
scheme of a series of procedures could be drawn as shown in Fig.11. Bone marrow-derived 
cells aspirated from the iliac crest are cultured two dimensionally for expansion then three 
dimensionally by RWV bioreactor, after while they are transplanted into the damaged area. 
The procedures for cell treatment and cell culture are core processes to produce engineered 
tissues with structural integrity and functionality. Strict measures to prevent contamination 
and human error are needed due to the direct use of unsterile products and laborious nature 
of culture operations. For ensuring a reliable process and good quality products (engineered 
cartilage), a processing system for RWV culture is necessary and was developed, in which 
an automatic rotation control (described in the last section) and an automatic medium 
exchange process are available under GMP level as shown in Fig.12. The automatic RWV 
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cell culture system mainly consists of three blocks, a CO2 incubator and two refrigerators. 
The CO2 incubator is equipped with an RWV system which rotates two vessels 
independently, stops their rotation when a change of medium is necessary, and moves the 
vessels outside of the incubator, where two robot arms grasp two syringes from the 
refrigerators ( one with fresh medium from the refrigerator beneath the incubator, the other 
for wasted medium from the refrigerator on the incubator) and moves them to the top and 
bottom of the vessel, inserts their needles into the caps of the vessel and changes the 
medium(Fig.13). After the medium exchange procedure, the robot arms deliver each syringe to 
each refrigerator, the vessel moves to the normal position and the rotation culture starts. In the 
rotation culture, the rotation speed is controlled by the method described in the last section. 
 
 
Fig. 11. Procedure for cartilage regeneration therapy using an RWV bioreactor and bone 
marrow cells 
This system limits its function in rotation culture, however, such automatic processing 
systems are generally inevitable for safety processing for future therapeutic applications in 
tissue engineering and cell therapy (Kino-oka et al., 2009). 
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Fig. 12. Automatic RWV Cell Culture System 
 
 
Fig. 13. Two vessels in the CO2 incubator in the automatic RWV culture system (left) and the 
vessel out of the incubator with two attached syringes (right) 
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